Cimicifuga Homaccord
FDA Label NDC 50114-1220

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Heel Inc for the product Cimicifuga Homaccord (NDC 50114-1220). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding keep out of reach of children, indications and usage, warnings, dosage and administration, active ingredient, inactive ingredient, purpose, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Keep Out Of Reach Of Children

Keep this and all medicines out of the reach of children.

Indications And Usage

For the temporary relief of:
  • Headache rising from the neck
  • Rheumatic pain in the neck, shoulders and back
  • Sciatic neuralgia


Warnings

If symptoms persist or worsen, a physician should be consulted. As with any drug, if you are pregnant or nursing a baby, seek the advise of a health care professional before using this product.

Dosage And Administration

Adults and children above 11 years: 10 drops orally, 3 times daily, or as directed by a physician. Consult a physician for use in children under 12 years of age.

Active Ingredient

Each 50 ml contains as active ingredients: Cimicifuga racemosa 2X, 10X, 30X, 200X 0.4 ml each; Strontium carbonicum 8X, 30X, 200X 0.1 ml each.

Inactive Ingredient

Inactive ingredients: Ethanol, Purified Water USP.

Purpose

Headache rising from the neck, Rheumatic pain in the neck, shoulders and back, Sciatic neuralgia

* Please review the disclaimer below.